Effect of cognitive-behavioral stress management on Covid 19 patients

The effectiveness of cognitive-behavioral stress management using the remote care system (application) of Covid 19 patients on the severity and duration of symptoms of this disease, psychological symptoms, psychosocial adaptation, cognitive status and changes in the level of ferritin and CRP and Spo2 in the blood of Covid 19 patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201205049610N1

Enrollment

Registered

2022-11-19

Start date

2021-01-04

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: training cognitive and behavioral techniques for stress management using the covid 19 Remote Care System (application) that is given to these patients online. Inter

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Covid 19 patients who have not been spend more than 5 days after the onset of their first symptoms and have been discharged from the hospital to continue quarantine at home. Having a smartphone Being literate

Exclusion criteria

Exclusion criteria: People who are too old or illiterate that to find information from them is difficult

Design outcomes

Primary

Measure	Time frame
Score of psychological symptoms (depression, anxiety and stress) in the 21-question questionnaire of depression, anxiety and stress Laweibond and Laweibond 1995. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using 21-question questionnaire of depression, anxiety and stress Laweibond and Laweibond 1995.;Psychosocial adaptation. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using the 160-question Bell Psychosocial Adjustment Questionnaire 1961.;Cognitive status. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using the standard questionnaire of Mini-Mental State Examination of Folstein et al. 1975.;Changes in ferritin and C-reactive protein blood levels and saturation of peripheral oxygen of covid 19 patients. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Perform a blood test to check the serum level of ferritin and C-reactive protein in the blood and check the percentage of saturation of peripheral oxygen in the blood using a pulse oximeter in two stages, before and after the intervention.;Severity and duration of Covid 19 disease symptoms. Timepoint: Daily monitoring of symptoms of covid 19 disease, from the first day of entry into the study to 21 days. Method of measurement: Evaluation of symptom severity by daily fever measurement and body pain scoring with McGill Pain Questionnaire and weakness scoring with Energy / Fatigue subscale from Quality of Life Questionnaire. duration of covid 19 disease symptoms by daily symptom monitoring and number of days recorded that each of the subjects experiences symptoms.	—

Measure

Time frame

Score of psychological symptoms (depression, anxiety and stress) in the 21-question questionnaire of depression, anxiety and stress Laweibond and Laweibond 1995. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using 21-question questionnaire of depression, anxiety and stress Laweibond and Laweibond 1995.;Psychosocial adaptation. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using the 160-question Bell Psychosocial Adjustment Questionnaire 1961.;Cognitive status. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Measurement of this variable using the standard questionnaire of Mini-Mental State Examination of Folstein et al. 1975.;Changes in ferritin and C-reactive protein blood levels and saturation of peripheral oxygen of covid 19 patients. Timepoint: Perform pre-test before the intervention and post-test after the intervention. Method of measurement: Perform a blood test to check the serum level of ferritin and C-reactive protein in the blood and check the percentage of saturation of peripheral oxygen in the blood using a pulse oximeter in two stages, before and after the intervention.;Severity and duration of Covid 19 disease symptoms. Timepoint: Daily monitoring of symptoms of covid 19 disease, from the first day of entry into the study to 21 days. Method of measurement: Evaluation of symptom severity by daily fever measurement and body pain scoring with McGill Pain Questionnaire and weakness scoring with Energy / Fatigue subscale from Quality of Life Questionnaire. duration of covid 19 disease symptoms by daily symptom monitoring and number of days recorded that each of the subjects experiences symptoms.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Hosseini naveh

Islamic Azad University

mn.h.h.naveh@gmail.com+98 31 3432 2616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026